Non-invasive enhancement of intracortical solute clearance using transcranial focused ultrasound.
Authors: Yoo SS, Kim E, Kowsari K, Van Reet J, Kim HC, Yoon K
Transport of interstitial fluid and solutes plays a critical role in clearing metabolic waste from the brain. Transcranial application of focused ultrasound (FUS) has been shown to promote localized cerebrospinal fluid solute uptake into the brain parenchyma; however, its effects on the transport and clearance of interstitial solutes remain unknown. We demonstrate that pulsed application of low-intensity FUS to the rat brain enhances the transport of intracortically injected fluorescent tracers (ovalbumin and high molecular-weight dextran), yielding greater parenchymal tracer volume distribution compared to the unsonicated control group (ovalbumin by 40.1% and dextran by 34.6%). Furthermore, FUS promoted the drainage of injected interstitial ovalbumin to both superficial and deep cervical lymph nodes (cLNs) ipsilateral to sonication, with 78.3% higher drainage observed in the superficial cLNs compared to the non-sonicated hemisphere. The application of FUS increased the level of solute transport visible from the dorsal brain surface, with ~ 43% greater area and ~ 19% higher fluorescence intensity than the unsonicated group, especially in the pial surface ipsilateral to sonication. The sonication did not elicit tissue-level neuronal excitation, measured by an electroencephalogram, nor did it alter the molecular weight of the tracers. These findings suggest that nonthermal transcranial FUS can enhance advective transport of interstitial solutes and their subsequent removal in a completely non-invasive fashion, offering its potential non-pharmacological utility in facilitating clearance of waste from the brain.
Introduction
Purpose
Other
Study Objective
To determine whether pulsed low-intensity transcranial focused ultrasound can noninvasively enhance the transport and clearance of intracortically injected interstitial solutes in the rat brain.
Animal model / Human subject
Sprague-Dawley Rats (Rattus norvegicus); sex: male
Disease model
healthy
Targeted brain region(s)
Cerebral cortex
Cargo name and characteristics
Ovalbumin and high molecular weight dextran
Route of administration
Intracortical injection
Outcomes and Safety
Summary of Outcomes
Transcranial low‑intensity pulsed FUS (100 ms pulses at 1 Hz, peak‑to‑peak ≈770 kPa, I_SPPA ≈4.4–4.7 W/cm2), applied without microbubbles for 30–60 min, significantly enhanced transport of intracortically injected tracers (45 kDa ovalbumin and 2000 kDa dextran) — increasing parenchymal distribution (ovalbumin +40.1%, dextran +34.6%), enlarging dorsal surface tracer area (~+43%) and fluorescence (~+19%), and augmenting ipsilateral superficial cervical lymph node drainage (~+78.3%) — without inducing EEG changes, tracer molecular‑weight alteration, tissue heating, or histological damage.
Duration of biological effect
30 min
Safety-related matter
No adverse effects were observed with the low‑intensity, pulsed FUS used: there were no EEG changes, negligible heating (<0.027°C), no alteration of tracer molecular weight, normal animal behaviour, and histology showed no tissue damage or hemorrhage after a 1‑week survival. The authors caution, however, that FUS with microbubbles can cause local hemorrhage and that applying FUS too soon after intracortical injection previously produced intracranial hemorrhage, so timing and avoiding MBs are important safety considerations.
Brain Region
Ultrasound Parameters
Ultrasound instrument
FUS transducer (Ultran Group)
FUS Frequency
0.2 MHz
FUS Intensity
ISPPA: 5 W/cm^2; ISPTA: 500 mW/cm^2
FUS Pressure
0.77 MPa
FUS Mode
pulsed
Pulse duration
100 ms
Duration of a single FUS session
30 min
Focal Characteristics
28 mm diameter, 22 mm radius of curvature
Treatment frequency
Single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search